A keratinocyte life cycle model identifies novel host genome regulation by human papillomavirus 16 relevant to HPV positive head and neck cancer
Authors:
Open Access
- 1 June 2017
- journal article
- research article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 8 (47) , 81892-81909
Abstract
Many aspects of the HPV life cycle have been characterized in cervical cell lines (W12, CIN612) and in HPV immortalized primary foreskin keratinocytes. There is now an epidemic of HPV positive oropharyngeal cancers (HPV16 is responsible for 80-90% of these); therefore increased understanding of the HPV16 life cycle in oral keratinocytes is a priority. To date there have been limited reports characterizing the HPV16 life cycle in oral keratinocytes. Using TERT immortalized “normal” oral keratinocytes (NOKs) we generated clonal cell lines maintaining the HPV16 genome as an episome, NOKs+HPV16. Organotypic raft cultures demonstrated appropriate expression of differentiation markers, E1^E4 and E2 expression along with amplification of the viral genome in the upper layers of the epithelium. Using this unique system RNA-seq analysis revealed extensive gene regulation of the host genome by HPV16; many of the changes have not been observed for HPV16 before. The RNA-seq data was validated on a key set of anti-viral innate immune response genes repressed by HPV16 in NOKs+HPV16. We show that the behavior of these NOKs+HPV16 lines is identical to HPV16 immortalized human tonsil keratinocytes with regards innate gene regulation. Finally, using The Cancer Genome Atlas (TCGA) data we examined gene expression patterns from HPV positive and negative head and neck cancers and demonstrate this innate immune gene signature set is also downregulated in HPV positive cancers versus negative. Our system provides a model for understanding HPV16 transcriptional regulation of oral keratinocytes that is directly relevant to HPV positive head and neck cancer.Keywords
This publication has 60 references indexed in Scilit:
- IFNβ‐dependent increases in STAT1, STAT2, and IRF9 mediate resistance to viruses and DNA damageThe EMBO Journal, 2013
- Integrative analyses reveal novel strategies in HPV11,-16 and -45 early infectionScientific Reports, 2012
- Epithelial Cell Responses to Infection with Human PapillomavirusClinical Microbiology Reviews, 2012
- The E7 Open Reading Frame Acts in cis and in trans To Mediate Differentiation-Dependent Activities in the Human Papillomavirus Type 16 Life CycleJournal of Virology, 2011
- The Inhibitory Action of P56 on Select Functions of E1 Mediates Interferon's Effect on Human Papillomavirus DNA ReplicationJournal of Virology, 2010
- Epigenetic Silencing of Interferon-κ in Human Papillomavirus Type 16–Positive CellsCancer Research, 2009
- Unphosphorylated STAT1 prolongs the expression of interferon-induced immune regulatory genesProceedings of the National Academy of Sciences, 2009
- Papillomaviruses in the causation of human cancers — a brief historical accountVirology, 2009
- An interferon-related gene signature for DNA damage resistance is a predictive marker for chemotherapy and radiation for breast cancerProceedings of the National Academy of Sciences, 2008
- Interferon‐inducible protein, P56, inhibits HPV DNA replication by binding to the viral protein E1The EMBO Journal, 2008